CRVS – corvus pharmaceuticals, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

CRVS

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

1/22

03:22 pm

crvs

Rating for CRVS

Low Report

Rating for CRVS

Report

1/22

03:22 pm

crvs

Rating for CRVS

Low Report

Rating for CRVS

Report

1/21

12:58 pm

crvs

Rating for CRVS

Medium Report

Rating for CRVS

Report

1/21

12:58 pm

crvs

Rating for CRVS

Medium Report

Rating for CRVS

Report

1/21

09:27 am

crvs

Rating for CRVS

Low Report

Rating for CRVS

Report

1/21

09:27 am

crvs

Rating for CRVS

Low Report

Rating for CRVS

Report

1/20

04:06 pm

crvs

Corvus Pharmaceuticals (NASDAQ:CRVS) had its "overweight" rating reaffirmed by analysts at Barclays PLC.

Medium Report

Corvus Pharmaceuticals (NASDAQ:CRVS) had its "overweight" rating reaffirmed by analysts at Barclays PLC.

Report

1/20

12:05 pm

crvs

Corvus Pharmaceuticals (NASDAQ:CRVS) had its "buy" rating reaffirmed by analysts at HC Wainwright.

High Report

Corvus Pharmaceuticals (NASDAQ:CRVS) had its "buy" rating reaffirmed by analysts at HC Wainwright.

Report

12/11

10:04 am

crvs

Corvus Pharmaceuticals (NASDAQ:CRVS) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.

Low Report

Corvus Pharmaceuticals (NASDAQ:CRVS) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.